The University of Pécs is an institution of higher education in Hungary. The year 1367 appears in the seal of the university, it has its roots in the medieval university founded in Pécs in 1367 by King Louis I the Great.

During the past decade, University of Pecs conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 10 clinical trials were completed. i.e. 58.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pecs" #1 sponsor was "University of Pecs" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Banyan Biomarkers, Inc" with 3 trials sponsored, "Biotronik SE & Co. KG" with 3 trials sponsored and "Amicus Therapeutics" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pecs" #1 collaborator was "European Union" with 6 trials as a collaborator, "Charite University, Berlin, Germany" with 5 trials as a collaborator, "Schoen Klinik Hamburg Eilbek" with 5 trials as a collaborator, "University College, London" with 5 trials as a collaborator and "University of Basel" with 5 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "University of Pecs" are "Systemic Sclerosis" (5 trials), "Acromegaly" (3 trials), "Coronary Artery Disease" (3 trials), "Heart Failure" (3 trials) and "Traumatic Brain Injury" (3 trials). Many other conditions were trialed in "University of Pecs" in a lesser frequency.

Most popular intervention types in "University of Pecs" are "Drug" (29 trials), "Other" (8 trials), "Device" (7 trials), "Biological" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "AT2221" (2 trials), "ATB200" (2 trials), "Azacitidine" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Pecs" are 53 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 12 active trials in "University of Pecs". 1 are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 34 completed trials in University of Pecs, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pecs, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".